the specific pathology all BSG must be considered malignant because their localization itself is inoperable (23). These tumors are most often localized in pons, often with infiltration in other regions of the brainstem (16). They characteristically present with multiple cranial nerve deficits, ataxia and long tract dysfunction (5,6,10). The simplest classification of BSG is into two groups as focal and diffuse (4, 8) . More complex grading system defined subtypes of tumors of the brainstem, according to localization, the presence of hydrocephalus and hemorrhage and growth model (5, 7, 11, 13) .
█ INTRODUCTION
T umors of the central nervous system are present in about 2% compared to all malignant tumors of the human population. They represent the leading cause of death from malignant tumors in children population and fourth in the adult population (21) . In the period before computed tomography (CT) and magnetic resonance imaging (MRI), all brainstem gliomas (BSG) were considered a pathological entity with a poor prognosis. Matson emphasized that regardless of Nine patients (17.6%) died during the follow-up period. Seven patients died within the first two months after the operation. Three patients died because of intrahospital infection with the clostridia. In two patients, there was development of edema and infarction in the pons. One patient died because of the development of pulmonary embolism five days after the operation. In one patient, there was development of acute renal failure five weeks after the operation. The eighth patient died during the fifth month after the operation due to the development of the meningitis because of the skin necrosis above the pump of the ventriculoperitoneal shunt. The ninth patient died during the 36 th month after the operation because █ mATERIAl and mEThODS This is a retrospective study. We present the results of 51 patients with brainstem tumors that were treated at the Institute of Neurosurgery, Clinical Center of Serbia in the period from 1.01.1998 until 31.12.2012. The analysis included gender, age at the time of symptom onset, duration of symptoms before diagnosis, initial symptoms and signs, radiological findings -intensities of the signals, the presence of necrosis and contrast staining, the extent of surgical resection and survival. All the patients were subjected to the MRI during preoperative diagnosis. The data were analyzed with SPSS 13.0 software package. The survival period is shown by Kaplan-Meyer's curve.
█ RESUlTS
Thirty-two patients (62.7%) were male and 19 patients (37.3%) were female, average age of the patients was 30.6±19.3 years with a median age of 29 and a minimum of 3 years and maximum 70 years. The average duration of symptoms prior to admission was 6.2±6.5 months with a median of 3 months. The minimum duration was 0.5 months, while the maximum duration was 36 months. The most common initial symptoms were hemiparesis (68.6%) and VII th nerve palsy (35.3%) while the least common was hemiplegia (9.8%) ( Table I ).
The most common clinical signs were pyramidal deficit (58.8%), VII th nerve paralysis (56.9%), papilledema of the optic nerve (43.1%), affection of the lower group of cranial nerves (35.3%), while the rarest clinical manifestations were trigeminal motor dysfunction and nystagmus (9.8%) ( Table II) .
The CT and MRI have been performed in all patients. Most patients had lesions located in pons (54.9%) and pontomedullary part (23.5%), with contrast staining (15.7%) at the periphery (27.5%) and exophytic component (70.59%).
Forty-eight (94.1%) patients were operated. In 39 cases (76.5%), the scope of operation was to reduce of tumor mass (Table III) . Initially after admission, ventriculoperitoneal shunt has been inserted in 12 patients because of the presence of hydrocephalus. Two of the patients underwent ventriculoperitoneal shunt insertion after the operation because of the development of hydrocephalus that had not been detected before the operation. The tumors with surface presentation on the ground of the fourth ventricle, tumors with exophytic component and distinctly restricted tumors were operated. The unclearly restricted tumors were also operated because of the histological verification of tumor (n=7, 13.7%). All patients were operated in half-seated position, with standard sub-occipital craniectomy for the access to the ground of IV th ventricle using telovelar approach. In cases in which there was no presentation on the surface and/or the exophytic portion of the tumor, we used a safe incision of the ground of IV th ventricle within supra-or infrafacial triangle. For the tumor located in the mesencephalon, we used the subtemporal approach.
Histological type astrocytoma grade I-II was predominant in younger patients, located in the pons with an exophytic component (Table IV) . Gliomas make up 40-60% of all primary brain tumors (14, 19) . BSG make up 1% of all brain tumors of adults and 10% of all brain tumors pediatric ages. Initial presentation of these tumors is represented by two peaks of incidence at 4-13 years and the fourth decade of life (9, 15, 30) . Supratentorial brain gliomas have a better prognosis in children than in adults, except glioma localized in the area of the brainstem where survival in children is significantly shorter than in adults (1, 3, 22, 27) .
MRI has unquestionable value in the topo-anatomic diagnostic of the brainstem tumors. The intensity of the contrast counting and the ability of the spectroscopic analysis in the great extent predict histological type of tumor. However, results of the numerous authors show that counting tumor with contrast absolutely is not a sign of malignancy and bad outcome (12, 15, 18, 19, 30) . Confirmation of specifics BSG lies in the of the diffuse infiltration of the brainstem with the tumor (initial histological findings were diffuse astrocytoma grade III) and postoperative radiotherapy was performed. The sixmonth survival, as well as one-year and two-year amounted to 84.3%, while the three-year survival was 81.5% ( Figure 1 -Kaplan-Meier). Patients with fatal outcome dominantly had ataxia, as initial symptom (HR:5.546, p = 0.012) (Figure 2) .
A radiotherapy protocol was used in 28 patients -where the volume at the operation meant biopsy -7 patients (4 Astrocytoma grade III and 3 Astrocytoma grade IV), in 19 (48.7%) patients where the volume at the operation meant reduction -(6 Astrocytoma grade II and 13 Astrocytoma grade III) and in two of the three patients who have not been surgically treated with good general condition (Karnofsky Index=80) and based on the MRI it was estimated that there was diffuse tumor of the brainstem. 
Follow-up in months Follow-up in months
diagnosis is essential for surgical planning in order to prevent additional neurological deficits. Precise histological verification enables prediction of growth model and determines the protocol for their further treatment. Diffuse BSG does not "respect" the anatomical barrier (nucleus of cranial nerves and nerve pathways) and has a predominantly high degree of malignancy. Low grade BSG in adults have focal growth, so that surgical reduction of the tumor mass without radical surgery to the healthy tissue, enables long lasting survival without the need for adjuvant oncology protocol and without additional neurological deficit.
█ REFERENCES fact that diffuse BSG rarely stain with contrast (8, 9, 28) . The short time interval between the occurrence of symptoms and the diagnosis, the presence of intra-tumoral necrosis and histologic verification of high grade BSG are predictors of shorter survival period (15, 25, 28, 30) . In our series (51 patients), the average duration of symptoms before hospital admission was 6.2±6.5 months with a median of 3 months. The minimum duration was 0.5 months, while the maximum duration was 36 months. The most common initial symptom was hemiparesis (68.6%) and VII th nerve palsy (35.3%) while the least common were hemiplegia (9.8%). In patients (n=9, 17.6%) with a fatal outcome, the dominating symptom was ataxia (HR:5.546, p=0.012). Age below 40 years, duration of symptoms longer than 3 months before diagnosis, Karnofsky score above 70, the absence of necrosis and discoloration with contrast to the MRI imaging and a low grade tumor type are indicators of long time survival of patients with BSG (27) . Surgical standard implies more radically removal of the tumor without additional neurological deficit (14, 19) . In our series, 48 patients were operated (94.1%). In 39 cases (76.5%), the extent of operation was to the level of reduction. The histological verification of tumors of the brainstem is difficult due to small quantities or unrepresentative part of taken tissue, especially in the case of stereotactic biopsy, so the need for a correct histological diagnosis imposes direct surgery as the method of choice (2, 20, 25, 30) . Hundsberger et al. (17) shows a series of 21 patients with BSG who initially presented by ataxia, paresis of oculomotor nerve, instability when walking and hemiparesis. Patients with malignant gliomas were older (48 years), and the average survival time was 5.8 months compared to the group of patients with gliomas with lower grade of malignancy (34 years) in which the average survival was 24.1 month (17) . In our series of 51 patients, 62.7% were male and 37.3% were female, mean age was 30.6±19.3 years. At the age 38.2±17.9 years, the most common tumor was high grade type of glioma (p=0.017). While low grade histological type was dominant in younger age 25.4±17.4 years (p=0.045), with localization in the pons (p=0.021) and exophytic component (p=0.049). The protocol of treatment of malignant BSG as includes in addition to radical resection and radiation therapy in the application of a single dose of 2 Gy to a range of 50-55 Gy (24, 26, 29) . In our series, a radiotherapy protocol was conducted in 28 patients, all in which the extent of operation included biopsy, in 19 patients in which the extent of operation included reduction (48.7%), and in 2 out of 3 patients who did not undergo surgical treatment. Nine patients (17.6%) had a lethal outcome during the follow-up period. Seven patients died in the first two months, while the eighth patient died five months after surgery, and the ninth patient died 36 months after surgery. The six-month survival, as well as one-year and two-year amounted to 84.3%, while the three-year survival was 81.5%. Ruben et al. emphasizes that chemotherapy after radiation increases the risk of radio-necrosis five times (26) .
█ CONClUSION
Even though the tumors of the brainstem are heterogeneous in growth model and localization, precise neuroradiological
